A3U-24016-99071
2 vaccinations
7 coded responses
22 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 374 / TN
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Autoimmune disorder — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: I have connective tissue autoimmune disease.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Visual field defect, Vitreous floaters — Feeling: Poor · Site: Pain · Headache · Be unable to do your normal daily activitiesFree text: 1st time ever experienced bright white arc lights in peripheral vision and floaters in my left eye.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 1MedDRA: Connective tissue disorder, Headache, Telemedicine, Visual field defect, Visual impairment, Vitreous detachment, Vitreous floaters — Feeling: Fair · Headache · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Ophthalmologist has confirmed I experienced "Vitreous Detachment" in my left eye on 3/28/21. Saw bright white arc lights in my peripheral vision and "cobweb" floaters in my left eye on 3/28/21. Had sharp short-lived headache in my left temple. Experienced black dot floaters and some fuzziness in left eye on 3/29/21. NOTE: I have Connective Tissue autoimmune disease and take 200MG Hyroxychloroquine daily. · Healthcare visit (other): 3/29/21 Telehealth visit with Ophthalmology Technician. 4/1/21 in-person appointment scheduled with Ophthalmologist.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetiteFree text: Lack of appetite for the last 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaFree text: Lack of appetite for the last 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetiteFree text: Lack of appetite for the last 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetiteFree text: Lack of appetite for the last 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-19
- 2021-04-23
- 2021-05-01
- 2021-05-09
- 2021-05-14
- 2021-05-22
- 2021-05-28
- 2021-07-16
- 2021-10-15
- 2022-01-19
- 2022-04-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): I have connective tissue autoimmune disease.
Systemic reaction (other): 1st time ever experienced bright white arc lights in peripheral vision and floaters in my left eye.
Systemic reaction (other): Ophthalmologist has confirmed I experienced "Vitreous Detachment" in my left eye on 3/28/21. Saw bright white arc lights in my peripheral vision and "cobweb" floaters in my left eye on 3/28/21. Had sharp short-lived headache in my left temple. Experienced black dot floaters and some fuzziness in left eye on 3/29/21. NOTE: I have Connective Tissue autoimmune disease and take 200MG Hyroxychloroquine daily.
Healthcare visit (other): 3/29/21 Telehealth visit with Ophthalmology Technician. 4/1/21 in-person appointment scheduled with Ophthalmologist.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Lack of appetite for the last 2 days
Systemic reaction (other): Lack of appetite for the last 2 days
Systemic reaction (other): Lack of appetite for the last 2 days
Systemic reaction (other): Lack of appetite for the last 2 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Telemedicine | ✓ | ✓ | ✓ |
| SRO | Autoimmune disorder | ✓ | ✓ | ✓ |
| SRO | Connective tissue disorder | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Visual field defect | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
| SRO | Vitreous detachment | ✓ | ✓ | ✓ |
| SRO | Vitreous floaters | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release